Jackson, Jazmyne L.
Finch, NiCole A.
Baker, Matthew C.
Kachergus, Jennifer M.
DeJesus-Hernandez, Mariely
Pereira, Kimberly
Christopher, Elizabeth
Prudencio, Mercedes
Heckman, Michael G.
Thompson, E. Aubrey
Dickson, Dennis W.
Shah, Jaimin
Oskarsson, Björn
Petrucelli, Leonard
Rademakers, Rosa
van Blitterswijk, Marka https://orcid.org/0000-0002-3054-7053
Funding for this research was provided by:
National Institutes of Health (R21 NS099631)
National Institutes of Health (R35 NS097261)
National Institutes of Health (R35 NS097273)
National Institutes of Health (P01 NS084974)
National Institutes of Health (P01 NS099114)
Amyotrophic Lateral Sclerosis Association (18-IIA-417)
Robert Packard Center for ALS Research, Johns Hopkins University (N/A)
Muscular Dystrophy Association (602854)
Mayo Clinic Foundation (N/A)
Article History
Received: 29 October 2019
Accepted: 14 January 2020
First Online: 30 January 2020
Ethics approval and consent to participate
: All subjects agreed to be in the study, and biological specimens were obtained after informed consent with approval from the Mayo Clinic Institutional Review Board (IRB).
: MDJ and RR hold a patent on methods to screen for the hexanucleotide repeat expansion in the <i>C9orf72</i> gene. No other competing interests were declared.